Session Details

Tuesday Posters - ADHD

Tuesday, 10 February 2004 16:00 -17:00

Hall 5, Exhibition Halls

Posters will be on display from Tuesday, 10 February until Thursday, 12 February.

Presenters will be in attendance to discuss their posters in this topic between 16:00-17:00 on Tuesday, 10 February.

Acute efficacy of Atomoxetine in the treatment
  • Albert J Allen, Lilly Research Laboratories, United States
    • Atomoxetine in the long-term prevention of relapse in ADHD
  • Mr Philip Hazell, Child and Youth Mental Health Service, Australia
    • Update: Long-term safety of Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder
  • Mr Peter D Feldman, Lilly Research Laboratories, United States
    • Relations between striatal dopamine transporter density and DAT-1 gene in adults with ADHD
  • Dr Klaus-Henning Krause, Friedrich Baur Institute, University of Munich, Germany
    • Platelet monoamine oxidase activity and SNAP-IV symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents
  • Evelyn Kiive, University of Tartu, Estonia
    • Treating autism with antiandrogenics and antipsychotics
  • Helmut Niederhofer, Hospital of Bolzano / Pediatria, Italy
    • Reduced hypothalamic-pituitary adrenal axis activity in children with attention deficit hyperactivity disorder and matched controls
  • Dr Dirk EM van West, University Centre of Child and Adolescent Psychiatry Antwerp, Belgium